Search

You searched for "screening"

579 results found

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy

1 September 2018 | | URO - Urologic Oncology
There is increasing evidence for the role of radical prostatectomy in select patients with T3-T4 prostate cancer (as part of multimodal therapy). This retrospective multicentre study explored the benefit of neoadjuvant hormonal therapy before radical prostatectomy specifically in patients with...

Discovering urology during the foundation programme

6 November 2024 | | URO - Core Urology
My journey to finding urology as a chosen career was not linear. During medical school, I always enjoyed studying urological and renal pathologies. I was exposed to one week of urology placement during my fourth year ‘surgical block’, where I...

The doctor as the patient: receiving bad news

13 March 2023 | URO - Urologic Oncology
This article, written by a GP working in the NHS, gives a unique insight into the experience of being a urology patient and some thoughtful advice on ‘breaking bad news’. Day 1 Alarm bells ring. It’s spotting an email from...

Meeting in the middle: a review of the rendezvous technique to treat impassable ureteric strictures and transected ureters

1 August 2015 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology
Introduction Complex ureteric strictures present a significant challenge with some patients undergoing multiple separate urological and radiological procedures to try to cross a stricture without success. Cross-departmental collaboration with uroradiology may allow a decrease in the number of separate interventions....

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | URO - Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...

So you want to go on a fellowship – part II: the research year

1 November 2016 | | URO - Core Urology
This article is the second in a three-part series which follows directly on from the first part which concentrated on the rationale for going on a fellowship, as well as some of the administrative hurdles you might face in planning...

ICS updates on continence care: making sense of detrusor underactivity and the underactive bladder

1 July 2016 | | URO - Functional / Reconstructive Urology
Countless epidemiological studies have established the frequent occurrence of lower urinary tract symptoms (LUTS) and the significant burden these symptoms incur. For the most part of the past three decades, there has been an overwhelming focus on detrusor overactivity (DO)...

‘No Deal’ Brexit – how might it impact urological practice in the UK?

1 September 2018 |
On 29 March 2017, the Government of the United Kingdom of Great Britain & Northern Ireland triggered Article 50 of the Lisbon Treaty, formally starting the two-year period for talks with the European Union (EU) in which to reach a...

Training to be a urologist: how risky is it?

1 May 2018 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatric Urology, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology, URO - Technology
The NHS and urology face challenging times in trying to provide quality patient care efficiently and economically. Urology trainees are experiencing conflicting pressures with a new contract, a challenging on-call system and changing training requirements in an overstretched, centralised service...

Ambulatory local anaesthetic implantation of percutaneous sacral nerve stimulators

11 July 2023 | | URO - Functional / Reconstructive Urology
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...

The role of PET-CT imaging in prostate cancer

4 October 2021 | | URO - Urologic Oncology
Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...

Medical journal readers

1 November 2014 | | URO - Technology
Keeping up to date with a variety of urology and medical journals can be an onerous task. Each year there is an ever-expanding number of medical journals and finding a way to sift through relevant information in medical journals and...